Platinum Partners
Media Advisory / Invitation to Attend - The Demand for Skilled Workers in the Kitchener-Waterloo, Dufferin Bio-Manufacturing Sector, a Discovery Session
KITCHENER and WATERLOO, ON, Feb. 3, 2012 /CNW/ - The Workforce Planning Board of Waterloo, Wellington, Dufferin and BioTalent Canada invite the media to attend a luncheon and discovery session on the labour needs of
SemBioSys to Present its New Joint Venture's Prospects to Investors at GCFF Vancouver Conference 2012
CALGARY, Feb. 3, 2012 /CNW/ - SemBioSy s Genetics Inc. (TSX:SBS) today announced the Company has been invi ted to participate in the GCFF Vancouver Conference 201 2 to be held tomorrow, February 4, 2012, at
Aeterna Zentaris Reports Updated Phase 1 Trial Results for AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer at ASCO GCS Meeting
QUÉBEC CITY, Feb. 3, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today reported positive updated results for the Phase 1 portion of its ongoing Phase 1/2 study in
Medicago Announces Investment in Quebec City Pilot Production Facility
QUEBEC CITY, Feb. 3, 2012 /CNW/ - Medicago Inc. (TSX : MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies
IGEN Networks Corporation Prepares to List on the CNSX
VANCOUVER, Feb. 2, 2012 /CNW/ - IGEN Networks Corporation is pleased to announce its intention to list on the Canadian National Stock Exchange (CNSX). Along with its OTCBB presence, IGEN will offer opportunities
MedMira Board of Directors Elected at Annual General Meeting
HALIFAX, Feb. 2, 2012 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a developer and marketer of rapid diagnostic technology and solutions, today announced that the Company's Board of Directors was elected at
SemBioSys and Tasly Pharmaceutical Joint Venture Receives Chinese Government Approvals and Business License
New Joint Venture Focused on Multi-Million Dollar Short-Term Revenue Opportunities
Guided Therapeutics Selects CAN-med Healthcare to Distribute LuViva® Advanced Cervical Scan in Canada
NORCROSS, GA and HALIFAX, Feb. 1, 2012 /CNW/ - Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has signed a definitive agreement granting CAN-med Healthcare exclusive distribution
Quebec is first in Canada to provide access to innovative treatment, XGEVA
Prostate and breast cancer patients in Quebec now have access to XGEVA, a first-in-class treatment that reduces the risk of bone complications
SeaWell Networks Inc. secures $5 million in Series B investment
TORONTO, Feb. 1, 2012 /CNW/ - MaRS client SeaWell Networks Inc., a leader in multi-platform video delivery software for network operators, announced that it has secured $5 million in Series B investment. Led by
MedMira Receives New Andurja Equity Investment of $ 1 million
HALIFAX, Jan. 31, 2012 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a developer and marketer of rapid diagnostic technology and solutions, today announced that it has entered into an agreement with Andurja
Kerry to Expand Center of Excellence with New Cell Science Laboratory Serving Bio-Pharma Customers Globally
BELOIT, Wis., Jan. 31, 2012 /CNW/ - Kerry Ingredients & Flavours is